James Liu1, Mei Wang2, David Tulman2, Sree H Mandava1, Katherine N Elfer2, Andrew Gabrielson1, Weil Lai1, Caleb Abshire1, Andrew B Sholl3, J Quincy Brown2, Benjamin R Lee4. 1. Department of Urology, Tulane University School of Medicine, New Orleans, LA. 2. Department of Biomedical Engineering, Tulane University, New Orleans, LA. 3. Department of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, LA. 4. Division of Urology, University of Arizona College of Medicine, Tucson, AZ. Electronic address: brlee@surgery.arizona.edu.
Abstract
OBJECTIVE: To present a novel imaging technique used for rapid, nondestructive histological assessment of renal neoplasias using a dual-component fluorescence stain and structured illumination microscopy (SIM). MATERIALS AND METHODS: After Institutional Review Board approval, 65 total biopsies were obtained from 19 patients undergoing partial or radical nephrectomy. Biopsies were stained with a dual-component fluorescent, and optically sectioned SIM images were obtained from the surface of the intact biopsies. Specimens were subsequently fixed and analyzed using hematoxylin and eosin (H&E) histopathologic methods and compared with SIM images. A single, board-certified pathologist blinded to specimens reviewed all SIM images and H&E slides, and determined the presence or absence of neoplasias. Results of blinded diagnosis of SIM were validated against traditional pathology. RESULTS: Of the 19 patients, 15 underwent robotic partial nephrectomies and 4 underwent laparoscopic nephrectomies. Indications included clinical suspicion of renal cell carcinoma. In total, 65 biopsy specimens were available for review. Twenty-one specimens were determined to be neoplastic on H&E, whereas 41 represented benign renal tissue. The final sensitivity and specificity of our study were 79.2% and 95.1%, respectively. CONCLUSION: SIM is a promising technology for rapid, near-patient, ex vivo renal biopsy assessment. By improving the ability to rapidly assess sufficiency of biopsy specimens and enabling immediate diagnostic capability, SIM aids in more effective biopsy performance, tissue triage, and patient counseling regarding management options. Additionally, because tissue is preserved, effective utilization of downstream diagnostic tests and molecular assessments are possible.
OBJECTIVE: To present a novel imaging technique used for rapid, nondestructive histological assessment of renal neoplasias using a dual-component fluorescence stain and structured illumination microscopy (SIM). MATERIALS AND METHODS: After Institutional Review Board approval, 65 total biopsies were obtained from 19 patients undergoing partial or radical nephrectomy. Biopsies were stained with a dual-component fluorescent, and optically sectioned SIM images were obtained from the surface of the intact biopsies. Specimens were subsequently fixed and analyzed using hematoxylin and eosin (H&E) histopathologic methods and compared with SIM images. A single, board-certified pathologist blinded to specimens reviewed all SIM images and H&E slides, and determined the presence or absence of neoplasias. Results of blinded diagnosis of SIM were validated against traditional pathology. RESULTS: Of the 19 patients, 15 underwent robotic partial nephrectomies and 4 underwent laparoscopic nephrectomies. Indications included clinical suspicion of renal cell carcinoma. In total, 65 biopsy specimens were available for review. Twenty-one specimens were determined to be neoplastic on H&E, whereas 41 represented benign renal tissue. The final sensitivity and specificity of our study were 79.2% and 95.1%, respectively. CONCLUSION: SIM is a promising technology for rapid, near-patient, ex vivo renal biopsy assessment. By improving the ability to rapidly assess sufficiency of biopsy specimens and enabling immediate diagnostic capability, SIM aids in more effective biopsy performance, tissue triage, and patient counseling regarding management options. Additionally, because tissue is preserved, effective utilization of downstream diagnostic tests and molecular assessments are possible.
Authors: Christopher B Dechet; Horst Zincke; Thomas J Sebo; Bernard F King; Andrew J LeRoy; George M Farrow; Michael L Blute Journal: J Urol Date: 2003-01 Impact factor: 7.450
Authors: Mei Wang; Hillary Z Kimbrell; Andrew B Sholl; David B Tulman; Katherine N Elfer; Tyler C Schlichenmeyer; Benjamin R Lee; Michelle Lacey; J Quincy Brown Journal: Cancer Res Date: 2015-08-17 Impact factor: 12.701
Authors: Sero Andonian; Zeph Okeke; Brian A VanderBrink; Deidre A Okeke; Chiara Sugrue; Patricia G Wasserman; Lee Richstone; Benjamin R Lee Journal: BJU Int Date: 2008-11-19 Impact factor: 5.588
Authors: Mei Wang; David B Tulman; Andrew B Sholl; Sree H Mandava; Michael M Maddox; Benjamin R Lee; J Quincy Brown Journal: J Biophotonics Date: 2017-10-05 Impact factor: 3.207